Q BioMed Inc. ”Q“ (OTCQB: QBIO) is a biomedical acceleration and development company that is focused on acquiring companies and biomedical assets, and the company is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need, according to the company’s website (see here: www.QBioMed.com). SNNLive spoke with Denis Corin, Chairman and CEO of Q BioMed Inc. at the SeeThruEquity & The Brewer Group's 2nd Annual Innovations Investor Conference 2016 in Miami, FL.
In this video interview, Mr. Corin and our host discuss the following topics:
- Overview of Q BioMed Inc.
- Company’s business model and criteria
- Discusses recent acquisitions
- Q BioMed team
- Frequency of adding new companies/technologies to the portfolio
- Growth drivers, milestones and goals for 2016
For more information about Q BioMed Inc., go to: www.QBioMed.com
The interview may contain forward looking statements about Q BioMed Inc.. See Q BioMed's periodic filings with the Securities and Exchange Commission for more complete information.
© 2017 Stock News Now
Supported by Superior Web Solutions